Skip to main content
Top
Published in: European Journal of Epidemiology 1/2017

01-01-2017 | CORRESPONDENCE

Reply to Greenland: A serious misinterpretation of a consistent inverse association of statin use with glioma across 3 case–control studies

Authors: Corinna Seliger, Christoph R. Meier, Claudia Becker, Susan S. Jick, Ulrich Bogdahn, Peter Hau, Michael F. Leitzmann

Published in: European Journal of Epidemiology | Issue 1/2017

Login to get access

Excerpt

We thank Dr. Greenland for raising an important issue concerning the interpretation of our data and we briefly respond to his points [1], as also presented in other recent articles [2, 3]. Before doing so, we would like to clarify that the title of his response is overstated because it leads the reader into believing that we interpreted the association between statin use and glioma as not being inverse across three studies. In contrast to the misleading wording of Dr. Greenland’s title, we interpreted the data of only one study (namely our own) as there being no association between statins and glioma [4], but consistently referred to previous studies [5, 6] as supporting an inverse relation between the two. …
Literature
1.
go back to reference Greenland S. A serious misinterpretation of a consistent inverse association of statin use with glioma across 3 case–control studies. Eur J Epidemiol (under production). Greenland S. A serious misinterpretation of a consistent inverse association of statin use with glioma across 3 case–control studies. Eur J Epidemiol (under production).
2.
go back to reference Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, Altman DG. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol. 2016;31:337–50.CrossRefPubMedPubMedCentral Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, Altman DG. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol. 2016;31:337–50.CrossRefPubMedPubMedCentral
4.
go back to reference Seliger C, Meier CR, Becker C, Jick SS, Bogdahn U, Hau P, Leitzmann MF. Statin use and risk of glioma: population-based case–control analysis. Eur J Epidemiol. 2016;31:947–52.CrossRefPubMed Seliger C, Meier CR, Becker C, Jick SS, Bogdahn U, Hau P, Leitzmann MF. Statin use and risk of glioma: population-based case–control analysis. Eur J Epidemiol. 2016;31:947–52.CrossRefPubMed
6.
go back to reference Gaist D, Andersen L, Hallas J, Sorensen HT, Schroder HD, Friis S. Use of statins and risk of glioma: a nationwide case–control study in Denmark. Br J Cancer. 2013;108:715–20.CrossRefPubMedPubMedCentral Gaist D, Andersen L, Hallas J, Sorensen HT, Schroder HD, Friis S. Use of statins and risk of glioma: a nationwide case–control study in Denmark. Br J Cancer. 2013;108:715–20.CrossRefPubMedPubMedCentral
Metadata
Title
Reply to Greenland: A serious misinterpretation of a consistent inverse association of statin use with glioma across 3 case–control studies
Authors
Corinna Seliger
Christoph R. Meier
Claudia Becker
Susan S. Jick
Ulrich Bogdahn
Peter Hau
Michael F. Leitzmann
Publication date
01-01-2017
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 1/2017
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-016-0212-0

Other articles of this Issue 1/2017

European Journal of Epidemiology 1/2017 Go to the issue